Tim Knotnerus

AM-Pharma & PRIMER BioBusiness
Tim joined AM-Pharma in 2012 and has since been responsible for Business Development. In 2015 he co-led the $600M option-to-acquisition deal between Pfizer and AM-Pharma. Ever since he also holds responsibility for alliance management between the two companies. Prior to AM-Pharma, Tim was a senior associate at Aescap Venture where he was instrumental in the financing and support of various portfolio companies including Avantium-the Netherlands, Biocartis-Switzerland, i-Optics-the Netherlands, Ethical Oncology Sciences (now Clovis)-Italy, and to-BBB-the Netherlands.

In 2016, he co-founded Primer BioBusiness Recruitment, a recruitment company focusing on commercial roles in the life sciences. Tim gained both a Science and Innovation Masters and a Drug Innovation Masters with honors from Utrecht University. He is an executive MBA candidate at IMD in Switzerland.


Join the community of BDP Life Sciences of Business Development professionals and Business leaders in Life Sciences & Health. Through our programmes you will connect with fellow participants, our speakers, coaches and alumni. Also connect with us online via LinkedIn.


Contribute to the development of future business leaders in Life Sciences & Health by becoming a speaker, mentor or sponsor of our programmes. Contact us to discuss the possibilities via info[at]bdplifesciences.com. 


Are you looking for a Business Development professional? Our partner PRIMER BioBusiness is specialised in the recruitment of commercial talent for the Life Sciences. Whether you need new talent, experienced professional ar an executive to lead your company, contact us to start your search.